Ghost Tree Capital’s Kite Pharma, Inc. KITE Stock Holding History

Ghost Tree Capital’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-60,000	Closed	-$3.46M	–	89
2014 Q4	$3.46M	Buy	+60,000	New	+$2.53M	1.66%	25

Other funds holding KITE

Cowen Inc New York $1.39B AUM 60.14% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

WCM

Wildcat Capital Management New York $106M AUM 0.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCSAM

Tyrus Capital S.A.M. Monaco $10.5M AUM 4.88% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Ghost Tree Capital's KITE Position: Q1 2015 in Review

Ghost Tree Capital sold out of Kite Pharma, Inc. (KITE) in Q1 2015, closing a stake of 60,000 shares — an estimated $3.46M sold.

Ghost Tree Capital first reported a position in KITE in Q4 2014 and held it in 1 quarter. The position peaked at $3.46M in Q4 2014. 148 funds tracked by Wall St. Rank hold KITE as of Q1 2015.

Ghost Tree Capital reported no remaining Kite Pharma, Inc. position as of Q1 2015 after selling out during the quarter.
Ghost Tree Capital sold 60,000 Kite Pharma, Inc. shares in Q1 2015, an estimated $3.46M.
Ghost Tree Capital first reported a position in Kite Pharma, Inc. in Q4 2014 and held it in 1 quarter.
Ghost Tree Capital's Kite Pharma, Inc. position peaked at $3.46M in Q4 2014.
148 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q1 2015.

Based on Ghost Tree Capital's 13F filing for Q1 2015, filed 15 May 2015.